Voxel touts FDA-cleared holography

Article

Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95). Voxel uses a

Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95).

Voxel uses a proprietary camera to create VoxGrams, or holographicimages, that seem to reach out into space when they are viewed.Voxel believes the enhanced perspective will help clinicians whenviewing images.

Voxel will show ongoing clinical work using VoxGrams in neurologicaland breast imaging. The company plans to begin beta-site installationsof the system next year.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.